Human ovarian cancer of the surface epithelium

Biochemical Pharmacology

Volumn 54, Issue 5, 1997, Pages 541-544

  Berchuck, Andrew ^a   Carney, Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Oncogene; Ovarian cancer; Ovary; p53 gene; Tumor suppressor gene

Indexed keywords

PROTEIN P53;

EPITHELIUM; FEMALE; GENE MUTATION; HUMAN; ONCOGENE; ONCOGENE C MYC; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030760558     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00061-0     Document Type: Note

References (32)

1. Whittemore AS, Harris R, Itnyre J and the Collaborative Ovarian Cancer Group, Characteristics relating to ovarian cancer risk. Collaborative analysis of twelve US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 136: 1184-1203, 1992.
2. Fredrickson TN, Ovarian tumors of the hen. Environ Health Perspect 73: 35-51, 1987.
3. Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL and Bast RC Jr, Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer. Am J Obstet Gynecol 164: 669-674, 1991.
4. Kohler M, Janz I, Wintzer HO, Wagner E and Bauknecht T, The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Anticancer Res 9: 1537-1547, 1989.
5. Rodriguez GC, Berchuck A, Whitaker RS, Schlossman D, Clarke-Pearson DL and Bast RC Jr, Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. Am J Obstet Gynecol 164: 745-750, 1991.
6. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin LJ, Stuart SG, Udove J, Ullrich A and Press MF, Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
7. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks S, McKenzie S, Yin S and Bast RC Jr, Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50: 4087-4091, 1990.
8. Rubin SC, Finstad CL, Wong GY, Almadrones L, Plante M and Lloyd KO, Prognostic significance of HER-2/neu expression in advanced ovarian cancer. Am J Obstet Gynecol 168: 162-169, 1993.
9. Kacinski BM, Mayer AG, King BL, Carter D and Chambers S, Neu protein overexpression in benign, borderline, and malignant ovarian neoplasms. Gynecol Oncol 44: 245-253, 1992.
10. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O and Rice JM, K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 50: 6139-6145, 1990.
11. Feig LA, Bast RC Jr, Knapp RC and Cooper GM, Somatic activation of rasK gene in a human ovarian carcinoma. Science 223: 698-701, 1984.
12. Haas M, Isakov J and Howell SB, Evidence against ras activation in human ovarian carcinomas. Mol Biol Med 4: 265-275, 1987.
13. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Birrer MJ, p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53: 3103-3108, 1993.
14. Mok SC-H, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS and Tsao S-W, Mutation of K-ras protooncogene in human ovarian epithelial tumors of border-line malignancy. Cancer Res 53: 1489-1492, 1993.
15. Tashiro H, Niyazaki K, Okamura H, Iwai A and Fukumoto M, c-myc overexpression in human primary ovarian tumors: Its relevance to tumor progression, Int J Cancer 50: 828-833, 1992.
16. Berchuck A, Rodriguez GC, Olt GJ, Boente MP, Whitaker RS, Arrick B, Clarke-Pearson DL and Bast RC Jr, Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am J Obstet Gynecol 166: 676-684, 1992.
17. Berchuck A, Olt GJ, Everitt L, Soisson AP, Bast RC Jr and Boyer CM, The role of peptide growth factors in epithelial ovarian cancer. Obstet Gynecol 75: 255-262, 1990.
18. Marth C, Lang T, Koza A, Mayer I and Daxenbichler G, Transforming growth factor-beta and ovarian carcinoma cells: Regulation of proliferation and surface antigen expression. Cancer Lett 51: 221-225, 1990.
19. Bartlett JMS, Rabiasz GJ, Scott WN, Langdon SP, Smyth JF and Miller WR, Transforming growth factor-β mRNA expression in growth control of human ovarian carcinoma cells. Br J Cancer 65: 655-660, 1992.
20. Jozan S, Guerrin M, Mazars P, Dutaur M, Monsarrat B, Cheutin F, Bugat R, Martel P and Valette A, Transforming growth factor β (TGF-β1) inhibits growth of a human ovarian cancer cell line (OVCCR1) and is expressed in human ovarian tumors. Int J Cancer 52: 766-770, 1992.
21. Zhou L and Leung BS, Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors α and α1. Biochim Biophys Acta 1180: 130-136, 1992.
22. Hurteau J, Rodriguez GC, Whitaker RS, Shain S, Bast RC Jr and Berchuck A, Effect of transforming growth factor-β on proliferation of human ovarian cancer cells obtained from ascites. Cancer 74: 93-99, 1994.
23. Daniels AM, McPherson JM, Daniels JR and Piez KA, Unusual antiproliferative effects of transforming growth factors-β1 and β2 against primary cells from human tumors. Biotherapy 1: 133-137, 1989.
24. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr and Berchuck A, Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51: 2979-2984, 1991.
25. Kohler MF, Kerns B-J, Humphrey PA, Marks JR, Bast RC Jr, and Berchuck A, Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81: 643-650, 1993.
26. Berchuck A, Kohler MF, Hopkins MP, Humphrey PA, Robboy SJ, Rodriguez GC, Super JT, Clarke-Pearson DL and Bast RC, Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol 52: 232-236, 1994.
27. Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr and Berchuck A, Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 85: 1513-1519, 1993.
28. Kupryjańczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, and Yandell DW, p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 90: 4961-4965, 1993.
29. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barnett JC, Skolnick MH, Kamb A and Wiseman R, BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994.
30. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
31. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King M-C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick M and Goldgar DE, A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273: 535-541, 1995.
32. Takahashi H, Behbakht K, McGovern PE, Chiu H-C, Couch FJ, Weber BL, Friedman LS, King M-C, Furusato M, LiVolsi VA, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rebane A, Cardonick A, Mikuta JJ, Rubin SC and Boyd J, Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55: 2998-3002, 1995.